• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

conformis

Conformis launches Cordera Match hip system

December 18, 2020 By Danielle Kirsh

Conformis (NSDQ:CFMS) this week launched its Cordera Match hip system in the U.S. The Cordera Match Hip System is an uncemented, primary total hip replacement system that features femoral and acetabular components. It is implanted using a surgeon-approved, personalized surgical plan and patient-specific instrumentation. “Our new Cordera Match hip system begins the expansion of our growing […]

Filed Under: Orthopedics Tagged With: conformis

Conformis up a bit on Street-beating Q3 report

November 4, 2020 By Nancy Crotti

Conformis (NSDQ:CFMS) shares rose slightly in after-hours trading today on third-quarter results that continued to reflect pandemic-related losses. The Billerica, Mass.-based joint replacement implant maker posted losses of -$6.18 million, or -9¢ per share, on sales of $15.98 million for the three months ended  September 30, 2020, for a 28.9% bottom-line gain on a sales decline […]

Filed Under: Business/Financial News, Orthopedics, Wall Street Beat Tagged With: conformis

Conformis hip system wins FDA clearance

October 14, 2020 By Danielle Kirsh

Conformis (NSDQ:CFMS) recently announced that it received FDA 510(k) clearance for its Cordera Hip System. The hip system is an uncemented, primary total hip replacement that features femoral and acetabular components. It can be used with or without a pre-operative CT scan that is used to design Conformis patient-specific instruments with a personalized surgical plan. “Our […]

Filed Under: Orthopedics Tagged With: conformis

Conformis to sell $17.25M in shares to investor

September 24, 2020 By Sean Whooley

Conformis (NSDQ:CFMS) announced today that it entered into a definitive agreement to sell approximately $17.25 million in shares and warrants. The agreement, made with an undisclosed “healthcare-focused” institutional investor, according to a news release, includes more than 8.5 million shares of Conformis’ common stock, accompanying warrants to purchase up to the same amount of shares and […]

Filed Under: Business/Financial News, Funding Roundup, Implants, Orthopedics Tagged With: conformis

MedTech 100 roundup: Stocks were practically unchanged last week

August 24, 2020 By Sean Whooley

Despite plenty of ups and downs coming in the stock market for the medtech industry, there was hardly any movement from week to week. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 89.6 points at the end of last week (Aug. 21). Overall, medtech stocks saw […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Mergers & Acquisitions, Research & Development, Wall Street Beat Tagged With: Bayer, Cala Health, cochlear, conformis, CureVac, Fractyl Laboratories, Johnson and Johnson, momentapharmaceuticals, Principia Biopharma, S&P, Sanofi, Stryker, Teva Pharmaceuticals

Conformis reaches second milestone in Stryker deal

August 20, 2020 By Sean Whooley

Conformis (NSDQ:CFMS) announced today that it completed the second of three milestones in its license and development agreement with Stryker (NYSE:SYK). Under the agreement, Conformis is set to receive an additional $3 million from Stryker after achieving the milestone as it develops patient-specific instrumentation (PSI) for use in connection with Stryker’s knee implant offerings. “We are pleased […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Funding Roundup, Implants, Orthopedics Tagged With: conformis, Stryker

Conformis names new marketing VP

August 14, 2020 By Sean Whooley

Joint replacement implant maker Conformis (NSDQ:CFMS) announced that it appointed Farzin Kaghani as its new VP of U.S. marketing. Khaghani, a veteran of more than 20 years in orthopedic and medtech sales and marketing, most recently served as president at NextStep Arthropedix, but before that, he spent more than 10 years at Conformis in a number […]

Filed Under: Business/Financial News, Orthopedics Tagged With: conformis, Personnel Moves

Conformis dips on Q2 losses

August 6, 2020 By Sean Whooley

Conformis (NSDQ:CFMS) shares dipped today on second-quarter results that highlighted losses influenced by the ongoing COVID-19 pandemic. The Billerica, Mass.-based joint replacement implant maker posted losses of -$2.1 million, or -3¢ per share, on sales of $19.5 million for the three months ended June 30, 2020, for a 68.4% bottom-line gain on a sales decline of […]

Filed Under: Business/Financial News, Implants, MassDevice Earnings Roundup, Orthopedics, Wall Street Beat Tagged With: conformis, coronavirus, COVID-19

The top 5 MassDevice stories of the week — July 31, 2020

July 31, 2020 By Chris Newmarker

The past week has seen a slew of Q2 earnings reports from medical device companies — and the picture overall hasn’t been pretty amid the COVID-19 pandemic. Still, medtech CEOs during their earnings calls said they’re starting to see some signs of hospital procedures recovering a bit even as the southern U.S. deals with a […]

Filed Under: Business/Financial News, Diagnostics, Dialysis, Digital Health, Featured, Orthopedics, Wall Street Beat Tagged With: Aetna, Ayogo Health, Baxter, conformis, coronavirus, COVID-19, Dexcom, Hologic, MassDevice Top Five, Smith+Nephew, Sorrento Therapeutics

Aetna accuses Conformis of trying to use patient’s lawsuit to compel coverage

July 27, 2020 By Chris Newmarker

Joint replacement implant maker Conformis (NSDQ:CFMS) is improperly using a Colorado man’s denial of benefits lawsuit to force Aetna to cover its customized knee implants, the health insurer recently argued in a federal court filing. Billerica, Mass.-based Conformis joined John Michael Schaub of Golden, Colo., in his lawsuit against Aetna, filed in May in U.S. District Court […]

Filed Under: Featured, Legal News, News Well, Orthopedics Tagged With: Aetna, conformis

Conformis expects 50% drop in Q2 product revenue

July 6, 2020 By Sean Whooley

Joint replacement implant maker Conformis (NSDQ:CFMS) said today that it anticipates a COVID-19-influenced 50% year-over-year drop in second-quarter product revenue. Releasing its preliminary results for the quarter ended June 30, the Billerica, Mass.-based company projected total revenue of $19.5 million for the quarter, which is down -1% year-over-year on a reported and constant currency basis. About […]

Filed Under: Business/Financial News, Implants, MassDevice Earnings Roundup, Orthopedics, Wall Street Beat Tagged With: conformis, coronavirus, COVID-19

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS